Cara Therapeutics Inc (NASDAQ:CARA) posted its quarterly earnings results on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.31. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was 3.44% in last session and finished the day at $19.25. Traded volume was 234.6K shares in the last session and the average volume of the stock remained 298.33K … Continue reading Biotech Most Volatile: Cara Therapeutics Inc (NASDAQ:CARA), Prothena Corporation (NASDAQ:PRTA), CorMedix Inc. (NYSEMKT:CRMD), Stemline Therapeutics (NASDAQ:STML)